SpliSense raises up to $13M in a funding round led by Cystic Fibrosis Foundation to support the clinical development of SPL84, its lead therapy for cystic fibrosis.
Amount Raised
$13 Million
Round Type
Funding Round
JerusalemBiotechnologyHealth CareTherapeuticsInvestors
Description
SpliSense, a Jerusalem-based biotechnology company, raised up to $13M in funding. The round was led by Cystic Fibrosis Foundation. The company plans to use the funds for the clinical development of its lead therapy for cystic fibrosis. This funding aims to advance SpliSense's efforts in developing therapies for pulmonary diseases.
Quick answer
SpliSense raised $13 Million in a Funding Round round, dated June 16, 2026. Investors: Cystic Fibrosis Foundation. SpliSense is based in Jerusalem, Jerusalem District, Israel.
- How much did SpliSense raise?
- SpliSense raised $13 Million in a Funding Round round on June 16, 2026.
- Who invested in SpliSense?
- Cystic Fibrosis Foundation is named as investors in this round.
- What does SpliSense do?
- SpliSense is a clinical-stage biotechnology company developing ASO-based therapies for pulmonary diseases.
- Where is SpliSense based and how big is it?
- SpliSense is based in Jerusalem, Jerusalem District, Israel.
- Who are the decision-makers at SpliSense?
- Fundz holds 1 contact at SpliSense, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as SpliSense that raised within 45 days of this round, from Fundz verified event records.
- Ratio Therapeutics raised $70M (Series C) on July 31, 2026.
- Hyku Biosciences raised $8.6M on July 30, 2026.
- HCW Biologics raised $1.5M (Post-IPO Equity) on July 29, 2026.
- Adjuvia Therapeutics raised $8M (Seed) on July 29, 2026.
- CORE Biomedicine raised $21M (Series A) on July 28, 2026.
- Torrey Pines Medicine raised an undisclosed amount (Angel) on July 28, 2026.
Who to call at SpliSense, and when
A new round usually means SpliSense is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SpliSense raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SpliSense, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SpliSense. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SpliSense raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
SpliSense raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.